FDA issued a Warning Letter to BioReliance Corporation on 1/5/2009 as a result of this inspection.
FDA investigators audited the BioReliance - Rockville, MD, United States facility and issued inspectional observations (via FDA 483) on 29 Sep 2008.
Add To Cart
- Category: Biologics
- Inspection end: 29 Sep 2008
- Location: Rockville, United States
- FEI: 1122041